Protalix BioTherapeutics, Inc.

US$2.54As of Sun 8 Nov 2026, 12:00 UTC
AMEX:PLXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (5.96%)
Div yield —
ROE 31.23%
Biotechnology
Beta (5Y) (0.02)
PE TTM 10.74
TSR TTM 7.17%
Mkt cap US$204.7M
ROIC 58.24%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.80
10.18%
294.16%
Hold 6|8|11|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
32.85%
20.93%
13.80%
12.16%
Revenue$M
19.68
19.68
20.70
21.86
10.22%
4.56%
8.93%
13.84%
Peers (US$204.7M)
Cap (US$)
PE
202.5M
—
203.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.816
0.638
0.560
EBIT/Intx
1.910
0.074
0.073
Own earn%
14.38
4.59
(6.73)
Sh yield%
28.37
38.95
38.94
Owners
Insiders/Inst%
14.99
38.18
Short interest%
2.30
SBC / revenue%
4.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
2–7
$1 testx
1.6
Incr. ROIC%
4